U.S. Markets close in 3 hrs 7 mins

Abbott Laboratories (ABT)


NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
50.75-0.05 (-0.09%)
As of 12:53PM EDT. Market open.
People also watch
ABBVBMYLLYJNJMRK
Full screen
Previous Close50.80
Open50.98
Bid50.80 x 200
Ask50.81 x 2400
Day's Range50.62 - 51.00
52 Week Range37.38 - 51.13
Volume2,403,279
Avg. Volume6,392,669
Market Cap88.07B
Beta1.54
PE Ratio (TTM)52.81
EPS (TTM)0.96
Earnings DateOct 17, 2017 - Oct 23, 2017
Dividend & Yield1.06 (2.08%)
Ex-Dividend Date2017-07-12
1y Target Est55.06
Trade prices are not sourced from all markets
  • Market Realist18 minutes ago

    Abbott Laboratories’ 2Q17 Results: Which Segment Fared Best?

    In 2Q17, Abbott Laboratories' (ABT) Medical Devices segment reported a strong performance once again, registering a YoY sales growth of 89.2%.

  • Market Realist2 hours ago

    Strong 2Q17 Results Trigger Rise in Abbott Stock

    On July 20, 2017, Abbott Laboratories (ABT) released its 2Q17 earnings. That day, ABT stock rose more than 4.0% from its closing price of $49.40 on July 19, 2017.

  • American City Business Journals21 hours ago

    Abbott deal will cost Alere three business units — and untold employees

    When it completes its $5.3 billion acquisition of Waltham-based Alere later this year, Abbott Laboratories will be getting one of the world’s largest makers of point-of-care diagnostic tests, a fast-growing sector. Thanks to antitrust rules, though, Abbott (ABT) will be taking on a slimmed-down version of Alere (ALR) by the end of September. Back in January, Illinois-based Abbott agreed to divest three Alere business units that make competing products in order to secure the approval of European Union antitrust regulators.